March 1 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO :
* Valeant Pharmaceuticals corrects misleading report about Salix investigation
* Valeant - SEC investigation into possible securities law violations by salix was first disclosed on April 30, 2015 in co's quarterly report on form 10-Q
* Valeant - investigation relates to legacy salix matters that precede acquisition of Salix by Valeant in April 2015
* Valeant-Corrected "erroneous" news report that mischaracterized timing of initiation of SEC investigation disclosed in form 10-K for year ended Dec 31, 2016 Source text for Eikon: ID:nCNWm7CCya Further company coverage: VRX.TO